UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota

Genome medicine, 2016-06, Vol.8 (1), p.67-67, Article 67

2016

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss

Surgery for obesity and related diseases, 2018-05, Vol.14 (5), p.708-714

2018

Link zum Volltext

Verfügbarkeit prüfen

Perceptions, behaviours and potential barriers to effective obesity care. Results from the ACTION‐DK study

Diabetes, obesity & metabolism, 2023-09, Vol.25 (9), p.2595-2604

2023

Link zum Volltext

Verfügbarkeit prüfen

The role of empagliflozin-induced metabolic changes for cardiac function in patients with type 2 diabetes. A randomized cross-over magnetic resonance imaging study with insulin as comparator

Cardiovascular diabetology, 2024-01, Vol.23 (1), p.13-13, Article 13

2024

Link zum Volltext

Verfügbarkeit prüfen

Investigating the roles of hyperglycaemia, hyperinsulinaemia and elevated free fatty acids in cardiac function in patients with type 2 diabetes via treatment with insulin compared with empagliflozin: protocol for the HyperCarD2 randomised, crossover trial

BMJ open, 2022-08, Vol.12 (8), p.e054100-e054100

2022

Link zum Volltext

Verfügbarkeit prüfen

Effects of Roux-en-Y Gastric Bypass on Fasting and Postprandial Levels of the Inflammatory Markers YKL-40 and MCP-1 in Patients with Type 2 Diabetes and Glucose Tolerant Subjects

Journal of Obesity, 2013-01, Vol.2013, p.361781-10

2013

Link zum Volltext

Verfügbarkeit prüfen

Canagliflozin or acarbose versus placebo to ameliorate post-bariatric hypoglycaemia - The HypoBar I randomized clinical trial protocol

Diabetic medicine, 2024-03, p.e15320-e15320

2024

Link zum Volltext

Verfügbarkeit prüfen

Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake

International Journal of Obesity, 2023-11, Vol.47 (11), p.1143-1151

2023

Link zum Volltext

Verfügbarkeit prüfen

Systems Signatures Reveal Unique Remission-path of Type 2 Diabetes Following Roux-en-Y Gastric Bypass Surgery

EBioMedicine, 2018-02, Vol.28 (C), p.234-240

2018

Link zum Volltext

Verfügbarkeit prüfen

Roux-en-Y gastric bypass versus sleeve gastrectomy: nationwide data from the Danish quality registry for treatment of severe obesity

Surgery for obesity and related diseases, 2022-04, Vol.18 (4), p.511-519

2022

Link zum Volltext

Verfügbarkeit prüfen

EMPA-REG: Glucose excretion and lipid mobilization – not storage – saves lives

Journal of diabetes and its complications, 2016-05, Vol.30 (4), p.753-753

2016

Link zum Volltext

Verfügbarkeit prüfen

The substantial costs to society associated with obesity - a Danish register-based study based on 2002-2018 data

Expert review of pharmacoeconomics & outcomes research, 2022-07, Vol.22 (5), p.823-833

2022

Link zum Volltext

Verfügbarkeit prüfen

Effects of Roux-en-Y gastric bypass on fasting and postprandial inflammation-related parameters in obese subjects with normal glucose tolerance and in obese subjects with type 2 diabetes

Diabetology and metabolic syndrome, 2015-02, Vol.7 (1), p.12-12, Article 12

2015

Link zum Volltext

Verfügbarkeit prüfen

Observation of Attractive and Repulsive Polarons in a Bose-Einstein Condensate

Physical review letters, 2016-07, Vol.117 (5), p.055302-055302, Article 055302

2016

Link zum Volltext

Verfügbarkeit prüfen

Dilute Fluid Governed by Quantum Fluctuations

Physical review letters, 2018-10, Vol.121 (17), Article 173403

2018

Link zum Volltext

Verfügbarkeit prüfen

Non-equilibrium quantum dynamics and formation of the Bose polaron

Nature physics, 2021-06, Vol.17 (6), p.731-735

2021

Link zum Volltext

Verfügbarkeit prüfen

Dilute Fluid Governed by Quantum Fluctuations

Physical review letters, 2018-10, Vol.121 (17), p.173403-173403

2018

Link zum Volltext

Verfügbarkeit prüfen

Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial

The Lancet (British edition), 2017-06, Vol.389 (10086), p.2304-2316

2017

Link zum Volltext

Verfügbarkeit prüfen

Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2021-12, Vol.326 (23), p.2375

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(21)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota

Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss

Perceptions, behaviours and potential barriers to effective obesity care. Results from the ACTION‐DK study

The role of empagliflozin-induced metabolic changes for cardiac function in patients with type 2 diabetes. A randomized cross-over magnetic resonance imaging study with insulin as comparator

Investigating the roles of hyperglycaemia, hyperinsulinaemia and elevated free fatty acids in cardiac function in patients with type 2 diabetes via treatment with insulin compared with empagliflozin: protocol for the HyperCarD2 randomised, crossover trial

Effects of Roux-en-Y Gastric Bypass on Fasting and Postprandial Levels of the Inflammatory Markers YKL-40 and MCP-1 in Patients with Type 2 Diabetes and Glucose Tolerant Subjects

Canagliflozin or acarbose versus placebo to ameliorate post-bariatric hypoglycaemia - The HypoBar I randomized clinical trial protocol

Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake

Systems Signatures Reveal Unique Remission-path of Type 2 Diabetes Following Roux-en-Y Gastric Bypass Surgery

Roux-en-Y gastric bypass versus sleeve gastrectomy: nationwide data from the Danish quality registry for treatment of severe obesity

EMPA-REG: Glucose excretion and lipid mobilization – not storage – saves lives

The substantial costs to society associated with obesity - a Danish register-based study based on 2002-2018 data

Effects of Roux-en-Y gastric bypass on fasting and postprandial inflammation-related parameters in obese subjects with normal glucose tolerance and in obese subjects with type 2 diabetes

Observation of Attractive and Repulsive Polarons in a Bose-Einstein Condensate

Dilute Fluid Governed by Quantum Fluctuations

Non-equilibrium quantum dynamics and formation of the Bose polaron

Dilute Fluid Governed by Quantum Fluctuations

Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial

Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial

Prevalence of antibodies against Brucella spp. in West Greenland polar bears (Ursus maritimus) and East Greenland muskoxen (Ovibos moschatus)

Prevalence of antibodies against Brucella spp. in West Greenland polar bears (Ursus maritimus) and East Greenland muskoxen (Ovibos moschatus)

Suchergebnisse filtern